Predictors and barriers to minimally adequate treatment among treated individuals with mental disorders: results from the World Mental Health Surveys

Abstract Background Treatments for mental disorders vary widely in type and quality, with many patients failing to receive treatments that meet even minimally adequate standards. We use data from the World Mental Health (WMH) surveys to investigate this variation by examining the prevalence and correlates of minimally adequate treatment (MAT) among patients receiving treatment for common mental disorders. Methods Data comes from 25 WMH cross-sectional surveys implemented in 21 countries (n = 1,838 respondents with n = 3,538 12-month treated disorders). MAT was defined according to widely used criteria: pharmacotherapy (≥ 1 month of medication with ≥ four visits to a healthcare provider) or counseling (≥ eight sessions with any provider). Multivariable regression analyses were used to examine associations of socio-demographic, disorder-related, and treatment-related factors with MAT. Results Approximately two-thirds (66.2%) of treated cases met MAT criteria. There was limited variation in MAT prevalence across disorder types, number of disorders, or years since disorder onset, but MAT prevalence was positively associated with increased disorder severity. Socio-demographic differences were nonsignificant. Relatively substantial differences in MAT prevalence were found by treatment sector (highest MAT prevalence among patients treated by mental health specialists and those treated by multiple provider types). Further analysis showed that these associations were explained by differences in premature discontinuation, completion of a full course of treatment that did not qualify as MAT, and still being in treatment at the time of interview that did not yet qualify as MAT. Low perceived disorder severity unrelated to more objective measures of severity was a central factor in accounting for premature discontinuation. Conclusions While approximately two-thirds of treated cases meet MAT criteria, significant gaps remain involving both premature discontinuation and cases where respondents reported completing a ‘full recommended course of treatment’ that did not involve enough visits or medication duration to meet the MAT standards. Expanding access to mental health specialty providers and increasing patient education about disorder severity would be useful in increasing the proportion of treated cases that receive MAT. Future research should focus on validating MAT definitions against clinical outcomes, standardizing assessment frameworks, and exploring provider- and system-level determinants of treatment adequacy.